Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blanchet

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapyJ S Blanchet, D Valmori, I Dufau, et al.
Revue Des Maladies Respiratoires|December 1, 2014
[Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians]D Debieuvre, C Locher, A-C Neidhardt, et al.
The British Journal of Dermatology|March 15, 2019
Most associations of early-life environmental exposures and genetic risk factors poorly differentiate between eczema phenotypes: the Generation R StudyC Hu, L Duijts, N S Erler, et al.
The British Journal of Dermatology|July 6, 2018
Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifaroteneJ Aubert, D Piwnica, B Bertino, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapyJ S Blanchet, D Valmori, I Dufau, et al.
Revue Des Maladies Respiratoires|December 1, 2014
[Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians]D Debieuvre, C Locher, A-C Neidhardt, et al.
The British Journal of Dermatology|March 15, 2019
Most associations of early-life environmental exposures and genetic risk factors poorly differentiate between eczema phenotypes: the Generation R StudyC Hu, L Duijts, N S Erler, et al.
The British Journal of Dermatology|July 6, 2018
Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifaroteneJ Aubert, D Piwnica, B Bertino, et al.
Pageof 10